About this trial
TITLE: RCT of air tamponade versus fluorinated gas tamponade for rhegmatogenous retinal detachment DESIGN: Non-inferiority RCT of 150 patients from 10 UK centres AIMS: To assess whether air tamponade is non inferior to gas tamponade for the repair of RRD treated with vitrectomy.
PRIMARY OUTCOME MEASURE: Primary anatomical success with single operation at 24 weeks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Primary uncomplicated RRD undergoing vitrectomy.
Phakic and pseudophakic eyes
Retinal breaks superiorly between 3 and 9 o'clock, and that are separated by less than 4 clock hours.
Disqualifiers
Absence of PVD
Age 40 years or younger
PVR grade C or above
Aphakia or anterior chamber lens
Trial design
Parallel
Treatments tested in this trial
air
Procedure/Surgeryuse of sterile air as a tamponade
Gas SF6 (Sulfur Hexafluoride) and others
Procedure/Surgeryuse of fluorinated gases such as SF6, C2F6 or C3F8 as a tamponade agent
Treatment groups
Trial outcomes
Primary outcomes
Primary anatomical success
Primary anatomical success at 24 weeks assessed by clinical examination by a retinal surgeon. The Outcome is binary with either 'successful retinal reattachement' or 'failed surgery'
Secondary outcomes
Post op visual acuity
Postoperative visual acuity at 10 days, 6 and 24 weeks measured either in Snellen or logMAR
Intraocular pressure
Day 1, Day 10-, 6- and 24-weeks intraocular pressure measured in mmHg
Quality of Life measures
Generic and vision related quality of life using the Euro quality of Life and Visual function questionnaire at 10 days, 6 and 24 weeks postoperatively. These questionnaires have sections relating to ocular health eg vision, ocular pain etc and impact on daily activities. They create a composite score combining each section, which ranges from 0-100 with higher scores reflecting better vision related quality of life.
Patient Satisfaction
Patient satisfaction with treatment using the Macular Disease Treatment Satisfaction Questionnaire at 10 days, 6 and 24 weeks. This questionnaire is a self administered questionnaire with a 7 point (0-6) scoring over 14 domains with a total score of 0-72, with higher scores reflecting greater satisfaction
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: